April 27, 2022 - April 29, 2022

Rainbow Children Medicare IPO Basis of Allotment

RAINBOW CHILDREN'S MEDICARE LIMITED

Our Company was originally incorporated as 'Rainbow Children's Medicare Private limited' under the provisions of the Companies Act, 1956 as a private limited company, at Hyderabad, Telangana. pursuant to a certificate of incorporation dated August 7, 1998, issued by the Registrar of Companies, Hyderabad at Telangana ("RoC") Subsequently, our Company was converted into a public limited company, and the name of our Company was (Ranged to ‘Rainbow Children's Medicare Limited' pursuant to a special resolution passed by the Shareholders of our Company on November 3, 2021 and a fresh certificate of incorporation was consequently issued by the RoC on November 20, 2021 under the Companies Act, 2013 For further details in relation to the changes to the name of our Company and the Registered Office, see 'History and Certain Corporate Matters' on page 294 of the prospectus dated May 2, 2022 ("Prospectus").

Registered Office: 8-2-120/103, 1 Survey No. 403. Road No. 2, Barbara Hills, Hyderabad - 500 034, Telangana, Telephone: +91 40 49692244.
Corporate Office: 8-2-19/1/A. Daulet Arcade, Road No. 11, Banjara Hills, Hyderabad - 500 034. Telangana, Telephone +91 40 49692244
Contact Person: Ashish Kapil, Company Secretary and Compliance Officer, E-mail: Companysecretary@rainbowhospital.in; Website: www.rainbowhospitals.com; Corporate Identity Number: U85110TG1998PIC029914
OUR PROMOTERS: DR. RAMESH KANCHARLA, DR. DINESH KUMAR CHIRLA AND DR. ADARSH KANCHARLA

Our Company has filed the Prospectus dated May 2, 2022 with the RoC and the Equity Shares are proposed to be listed on the National Stock Exchange of India Limited ("NSE") and the BSE Limited ("BSE") and the trading will commence on May 10, 2022.

BASIS OF ALLOTMENT

INITIAL PUBLIC OFFERING OF 29,168,579 EQUITY SHARES OF FACE VALUE OF RS 10 EACH ("EQUITY SHARES") OF RAINBOW CHILDREN'S MEDICARE LIMITED ("THE COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF Rs. 542 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF Rs. 532 PER EQUITY SHARE) ("OFFER PRICE") AGGREGATING TO Rs. 15,808.49 MILLION (THE "OFFER"), COMPRISING A FRESH ISSUE OF 5,167,679 EQUITY SHARES AGGREGATING TO Rs. 2,800 MILLION (THE "FRESH ISSUE") AND AN OFFER FOR SALE OF 24,000,900 EQUITY SHARES AGGREGATING TO Rs. 13,008.49 MILLION BY THE SELLING SHAREHOLDERS REFERRED TO IN ANNEXURE A ON PAGE 641 OF THE PROSPECTUS (THE "OFFER FOR SALE"). THE OFFER INCLUDED A RESERVATION OF UPTO 300,000 EQUITY SHARES AGGREGATING TO Rs. 156.60 MILLION (CONSTITUTING 0.30% OF THE POST-OFFER PAID-UP EQUITY SHARE CAPITAL) FOR SUBSCRIPTION BY ELIGIBLE EMPLOYEES (THE "EMPLOYEE RESERVATION PORTION"). THE OFFER LESS THE EMPLOYEE RESERVATION PORTION IS HEREINAFTER REFERRED TO AS THE "NET OFFER". THE OFFER AND THE NET OFFER WOULD CONSTITUTE 28.74%* AND 28.69%*, RESPECTIVELY, OF OUR POST-OFFER PAID-UP EQUITY SHARE CAPITAL.

^OUR COMPANY, DR. RAMESH KANCHARLA (ACTING ON BEHALF OF THE OTHER PROMOTER SELLING SHAREHOLDERS AND THE OTHER SELLING SHAREHOLDER) AND THE INVESTOR SELLING SHAREHOLDERS, IN CONSULTATION WITH THE BRLMS, OFFERED A DISCOUNT OF Rs. 20 TO ELIGIBLE EMPLOYEES BIDDING IN THE EMPLOYEE RESERVATION PORTION.

*PLEASE NOTE THAT THE OFFER AND THE NET OFFER % HAS BEEN ADJUSTED FOR THE FRESH ISSUE OF 5,167,679 EQUITY SHARES AND ALLOTMENT TO ELIGIBLE EMPLOYEE OF 44,118 EQUITY SHARES IN THE OFFER RESPECTIVELY.

OFFER PRICE: Rs. 542 PER EQUITY SHARE OF FACE VALUE OF Rs. 10 EACH
ANCHOR INVESTOR OFFER PRICE: Rs. 542 PER EQUITY SHARE OF FACE VALUE OF Rs. 10 EACH
THE OFFER PRICE IS 54.20 TIMES THE FACE VALUE OF THE EQUITY SHARES
Risks to Investors

•	The Offer Price is Rs. 542 per Equity Share. However, the average cost of acquisition per Equity Share for the Selling Shareholders is as follows:

Name of the Selling shareholder	Avg. cost of acquisition per Equity Share as on the date of the RHP (in Rs.)	Name of the Selling shareholder	Avg. cost of acquisition per Equity Share as on the date of the RHP (in Rs.)
Dr. Ramesh Kancharla (Promoter Selling Shareholder)	7.32	Mrs. Padma Kancharla (Other Selling Shareholder)	Nil
Dr. Dinesh Kumar Chirla (Promoter Selling Shareholder)	0.91	British International Investment plc (formerly known as CDC Group plc) (Investor Selling Shareholder)	54.50
Dr. Adarsh Kancharla (Promoter Selling Shareholder)	Nil	CDC India (Investor Selling Shareholder)	110.29

•	Our revenues are highly dependent on our hospitals in Hyderabad and Bengaluru. Of our 14 hospitals, six are situated in Hyderabad, Telangana and three are situated in Bengaluru, Karnataka. Any impact on the revenues from these hospitals could materially affect our business, financial condition and results of operations. The proportion of volumes at hospitals in Hyderabad and Bengaluru, of our aggregate inpatient and outpatient volumes across all our hospitals are as follows:

Particulars	Fiscal 2019	Fiscal 2020	Fiscal 2021	For the nine months period ended December 31, 2021
Proportion of volumes at hospitals in Hyderabad and Bengaluru to aggregate inpatient and outpatient volumes across all our hospitals	84.07%	81.89%	78.98%	77.28%

•	We are dependent on our medical professionals and our business and financial results could be impacted if we are not able to attract and retain such medical professionals. The attrition rate for our permanent employees, which includes nurses (including interns and paramedical personnel) are as follows:

Particulars	Fiscal 2019	Fiscal 2020	Fiscal 2021	For the nine months period ended December 31, 2021
Attrition rate for our permanent employees, which includes nurses (including interns and paramedical personnel)	35.41%	38.75%	45.50%	26.74%

•	The Offer Price, market capitalization to revenue multiple and price to earnings ratio based on the Offer Price of our Company, may not be indicative of the market price of our Company on listing or thereafter. The details of our price to earnings ratio and market capitalization to revenue from operations based on the Offer Price i.e. Rs. 542 per Equity Share are given below:

Particulars	Price to earnings ratio (based on diluted EPS)	Market capitalization to revenue
For the year ended March 31, 2021	127.53	7.91

For details of market capitalization to revenue multiple for our listed peers that have a similar business profile to us, please see "Basis for Offer Price" section at page 171 of the Prospectus.

•	Weighted average cost of acquisition of all shares transacted in last three years and one year preceding the date of the Prospectus:

Period	Weighted Average Cost of Acquisition^ (in Rs.)	Cap Price (Rs. 542) is X times the Weighted Average Cost of Acquisition	Range of acquisition price: Lowest Price - Highest Price^ (in RS)
Last 1 year	7.80	69.49	0.70
Last 3 years	7.80	69.49	0.70

^{^As certified by Madhu Mantri and Associates, Chartered
Accountants, in their certificate dated May 2, 2022.

•
We are significantly
dependent on certain specialties for a majority of our revenues. We have four core
specialties, namely secondary pediatric care, tertiary pediatric care, quaternary
pediatric care and women care (gynecology, obstetrics and related services), of which our
secondary pediatric care services have historically accounted for the largest portion of
our revenues. See "Our Business - Key Specialties - Pediatric services (including
secondary, tertiary and quaternary care)" on page 259 of the Prospectus.

BID/OFFER PROGRAMME

ANCHOR INVESTOR BIDDING
DATE WAS : TUESDAY, APRIL 26, 2022

BID/OFFER OPENED ON :
WEDNESDAY, APRIL 27, 2022

BID/OFFER CLOSED ON :
FRIDAY, APRIL 29, 2022

The Offer was made through the Book Building Process, in terms of Rules
19(2)(b) of the SCRR, read with Regulation 31 of the SEBI ICDR Regulations, and in
compliance with Regulation 6(1) of the SEBI ICDR Regulations, therein not more than 50% of
the Net Offer was available for allocation on a proportionate basis to Qualified
Institutional Buyers ("QIBs" and such portion, the "QIB Portion"),
provided that our Company, Dr. Ramesh Kancharta (acting on behalf of the other Promoter
Selling Shareholders and the Other Selling Shareholder) and the Investor Selling
Shareholders may, in consultation with the BRLMs, allocated up to 60% of the QIB Portion
to Anchor Investors on a discretionary basis (the "Anchor Investor Portion"),
of which one-third was reserved for domestic Mutual Funds, subject to valid Bids having
been received from domestic Mutual Funds at or above the Anchor Investor Allocation Price,
in accordance with the SEBI ICDR Regulations. Further, 5% of the Net QIB Portion was made
available for allocation on a proportionate basis only to Mutual Funds, and the remainder
of the Net QIB Portion was made available for allocation on a proportionate basis to all
QIBs, including Mutual Funds, subject to valid Bids having been received at or above the
Offer Price. Further, not less than 15% of the Net Offer was made available for allocation
to Non-Institutional Bidders ('Non-institutional Portion') of which one-third of the
Non-Institutional Portion was made available for allocation to Bidders with an application
size of more than Rs. 200,000 and up to Rs. 1,000,000 and two-thirds of the
Non-Institutional Portion was made available for allocation to Bidders with an application
size of more than Rs. 1,000,000 and under-subscription in either of these two
subcategories of Non-Institutional Portion was allocated to Bidders in the other
sub-category of Non-Institutional Portion, and not less than 35% of the Net Offer was made
available for allocation to Retail Individual Bidders in accordance with the SEBI ICDR
Regulations, subject to valid Bids being received at or above the Offer Price. All
potential Bidders, other than Anchor investors, were required to mandatorily utilise the
Application Supported by Blocked Amount ("ASBA") process by providing
details of their respective ASBA accounts and UPI ID (in case of Retail Individual Bidders
using UPI Mechanism), if applicable, in which the corresponding Bid Amounts was blocked by
the self-certified syndicate banks ("SCSBs") or under the UPI Mechanism,
as applicable to participate in the Offer Anchor Investors were not permitted to
participate in the Anchor Investor Portion through the ASBA process See "Offer
Procedure" on page 523 of the Prospectus.

The bidding for Anchor Investor opened and closed on Tuesday April 26,
2022. The Company received 36 applications from 23 anchor investors for 8,878,896 Equity
Shares. The Anchor Investor Offer Price was finalized at Rs. 542 per Equity Share. A total
of 8,663,404 Equity Shares were allocated under the Anchor Investor Portion aggregating to
Rs. 4,695,564,968.

The Offer received 254,335 applications for 257,733,603 Equity Shares
(inducing applications from Anchor Investors and prior to technical rejections) resulting
in Rs. 8.8331 times subscription. The details of the applications received In the Offer
from various categories are as under (before technical rejections):

SI no.
Category
No
of Applications applied
No.
of Equity Shares
Shares
Reserved as per Prospectus
No.
of times Subscribed
Amount
(Rs.)

A
Anchor Investors
36
8,878,896
8,663,404
1.0249
4,812,361,632

B
Qualified
Institution a Bidders (excluding Anchor Investors)
71
223,952,040
5,775,605
38.7755
121,382,005,680

C
Non-Institutional
Investors Upto Rs. 10 Lakhs
4,292
1,851,984
1,443,901
1.2826
1,005,242,238

D
Non-Institutional
Investors Upto Investors Upto Rs.10 Lakhs
4,414
14,755,797
2,887,803
5.1097
7,997
641,974

E
Retail
Individual Investors
244,404
8,208,297
10,107,308
0.8121
4,448,913,978

F
Eligible
Employee
1,118
86,589
300,000
0.2886
45,482,580

Total
254,335
257,733,603
29,178,021
8.8331
139,691,648,082

Final Demand

A summary of the final demand as at different Bid prices is as under

Sr
No.
Bid
Price
No.
of Equity Shares
%
to Total
Cumulative
Total
Cumulative
% of Total

1
516
197,100
0.08
197,100
0.08

2
517
9,666
0.00
206,766
0.08

3
518
6,939
0.00
213,705
0.08

4
519
1,647
0.00
215,352
0.08

5
520
42,012
0.02
257,364
0.10

6
521
4,104
0.00
261,468
0.10

7
522
8181
0.00
269,649
0.11

6
523
1,593
0.00
271,242
0.11

9
524
1,701
0.00
272,943
0.11

10
525
23,247
0.01
296,190
0.12

11
526
3,240
0.00
299,430
0.12

12
527
1458
0.00
300,888
0.12

13
528
1,998
0.00
302,886
0.12

14
529
7,560
0.00
310,446
0.12

15
530
38,367
0
01
348,813
0.14

16
531
2,673
0.00
351,486
0.14

17
532
4,887
0.00
356,373
0.14

18
533
575
0.00
357,048
0.14

19
534
1,242
0.00
358,290
0.14

20
535
17,280
0.01
375,570
0.15

21
536
2,268
0.00
377,838
0.15

22
537
1,431
0.00
379,269
0.15

23
538
4,590
0.00
383,859
0.15

24
539
1,620
0.00
385,479
0.15

25
540
23,139
0.01
408,618
0.16

26
541
10,341
0.00
418,958
0.16

27
542
243,844,776
95.31
244,263,735
95.47

28
CUTOFF
11,591,667
4.53
255,655,402
100.00

TOTAL
255,855,402
100.00

The Basis of Allotment was finalized in consultation with the
Designated Stock Exchange, being NSE on May 5, 2022

INVESTORS. PLEASE NOTE

The Employee Reservation as per the Prospectus was mentioned in amount
terms aggregating to not more than Rs. 156.60 million, translating to 300,000 Equity
Shares at Rs. 522 per Equity Share (after Employee discount of Rs. 20 per Equity Share).
Valid Bids received and considered for Allotment under Employee Category were for 44,118
Equity Scares amounting to Rs. 23.02 million. The unsubscribed portion was adjusted as
follows:

Particulars

No.
of Equity Shares
Amount
(in Rs.)

Employee
Reservation Portion in Rs. as per Prospectus
A
300,000
156,600,000

Valid Bids
considered for allotment
B
44,118
23,029,596

Deficit in RS
C
= (A-B)
255,882
133,570,404

Deficit in
Equity Shares
C/
Rs. 522 (after employee discount of Rs. 20 per Equity Share to the Offer Price)

255,862

No. of Shares
for Spillover
C
/ Rs. 542 (Offer Price)

246,440**

Difference in
Spillover due to Employee Discount

-9.442

** Unsubscribed portion of Employee Reservation Portion of 246,440
Equity Shares spilled over to QIBs, NIB and Retail Categories in the ratio of 50:15:35.

A.
Allotment to Retail
Individual Bidders (after technical rejections)

The Basis of Allotment to the
Retail Individual Bidders, who have bid at the Cut-Off Price or at the Offer Price of Rs.
542 per Equity Share, was finalized in consultation with NSE. This category has teen
subscribed lo the extent of 0.76967 times (including spillover from Employee category).
The total number of Equity Shares Allotted in Retail Portion is 7,845,660 Equity Shares
(including spillover of 86.254 Equity Shares from Employee category) to 234,230 successful
Retail Individual Bidder. The category details of the Basis of Allotment areas under:

Category
No.
of Applications Received
%
of Total
Total
No. of Equity Shares applied
%
to Total
No.
of Equity Shares allotted per Bidder
Ratio
Total
No. of Equity Shares Allotted

27
216,596
92.47
5,848,092
74.54
27
1.1
5,848,092

54
9,314
3.98
502,956
6.41
54
1.1
502.956

81
2,414
1.03
195,534
2.49
81
1.1
195,534

108
1,563
0.68
170,964
2.18
108
1.1
170,964

135
775
0.33
104,625
1.33
135
1.1
104,625

162
352
0.15
57,024
0.73
162
1.1
57,024

189
506
0.22
95,634
1.22
189
1.1
95,634

216
224
0.10
46,384
0.62
216
1.1
48,384

243
73
0.03
17,739
0
23
243
1.1
17,739

270
370
0.16
99,900
1.27
270
1.1
99,900

297
61
0.03
18,117
0.23
297
1.1
18,117

324
73
0.03
23,652
0.30
324
1.1
23,652

351
1,889
0.81
663,039
8.45
351
1.1
663,039

TOTAL
234,230
100.00
7,845,660
100.00

1.1
7.845.660

Unsubscribed portion of 2,261,648 Equity Shares spitted over to QIB and
NIB Categories in the ratio of 50.15

B.
Allotment to
Non-Institutional Bidders (Upto Rs. 10 Lacs) (after technical rejections)

The Bass of Allotment to the
Non-Institutional Bidders (Upto Rs. 10 Lacs) who have bid at the Offer Price of Rs. 542
per Equity Share or above, was finalized in consultation with NSE. The Non-Institutional
Portion (Upto Rs. 10 Lacs) has been subscribed to the extent of 1.11673 times (including
spillover from Employee and Retail Individual categories). The total number of Equity
Shares Allotted in this category is 1,636,831 Equity Shares (inducing spillover of 192,930
Equity Shares from Employee and Retail categories) to 4,242 successful Non-lns1itutional
Bidder. The category-wise details of the Basis of Allotment are as under: (Sample)

Category
No.
of Applications Received
%
of Total
Total
No. of Equity Shares applied
%
to Total
No.
of Equity Shares allotted per Bidder
Ratio
Total
No. of Equity Shares Allotted

378
3867
91.16
1,461,726
79.97
378
1:1
1,461,726

405
71
1.67
28,755
1.57
382
1:1
27,122

432
13
0.31
5,616
0.31
386
1:1
5,018

459
15
0.35
6,885
0.38
390
1:1
5.850

486
7
0.17
3,402
0.19
394
1:1
2,758

513
4
0.09
2,052
0.11
398
1:1
1,592

540
39
0.92
21,060
1.15
402
1:1
15,678

567
4
0.09
2,268
0.12
406
1:1
1,624

810
11
0.26
8,910
0.49
442
1:1
4,862

837
1
0.02
837
0.05
446
1:1
446

1,350
5
0.12
6,750
0.37
522
1:1
2,610

1,458
7
0.17
10,206
0.56
539
1:1
3,773

1,485
3
0.07
4,455
0.24
543
1:1
1,629

1,512
1
0.02
1,512
0.08
547
1:1
547

1,620
4
0.09
6,480
0.35
563
1:1
2,252

1,701
1
0.02
1,701
0.09
575
1:1
575

1,755
4
0.09
7,020
0.38
583
1:1
2,332

1,809
7
0.17
12,663
6.69
591
1:1
4,137

1,836
81
1.91
148,716
8.14
594
1:1
48,114

1*
67:81
57

TOTAL
4,242
100.00
1.827,900
100.00

1,636,831

*1 additional Equity Share has been allotted to Category 1,836 in the
ratio of 67:81

C.
Allotment to
Non-institutional Bidders (Above Rs. 10 Lacs) (after technical rejections)

The Bass of Allotment to the
Non-Institutional Bidders (Above Rs. 10 Lacs), who have bid at the Offer Price of Rs. 542
per Equity Share or above, was finalized in consultation with NSE. The Non-Institutional
Portion (Above Rs. 10 Lacs) has been subscribed to the extent of 4.47945 times (inducing
spillover of 385,860 Equity Shares from Employee and Retail Individuals categories). The
total number of Equity Shares Allotted in this category is 3,273,663 Equity Shares
including spillover from Employee and Retail categories) to 4,365 successful Non-
Institutional Bidder. The category-wise details of the Bass of Allotment are as under:
(Sample)

Category
No.
of Applications Received
%
of Total
Total
No. of Equity Shares applied
%
to Total
No.
of Equity Shares allotted per Bidder
Ratio
Total
No. of Equity Shares Allotted

1,863
4022
92.14
74,92,986
51.10
563
1:1
22,64,386

1
19:73
1,047

1,998
1
0.02
1,998
0.01
580
1:1
580

2,025
17
0.39
34,425
0.23
583
1:1
9,911

2,052
1
0.02
2,052
0.01
587
1:1
587

2,106
6
0.14
12,636
0.09
594
1:1
3,564

2,160
4
0.09
8,640
0.06
600
1:1
2,400

13,500
1
0.02
13.500
0.09
2,015
1:1
2,015

13,851
1
0.02
13,851
0.09
2,059
1:1
2,059

16,227
1
0.02
16,227
0.11
2,355
1:1
2,355

16,470
1
0.02
16,470
0.11
2,386
1:1
2,386

92,259
1
0.02
92,259
0.63
11,641
1:1
11,841

100,008
2
0.05
200,016
1.36
12,808
1:1
25,616

110,700
1
0.02
110,700
0.75
14,142
1:1
14,142

184,491
2
0
05
368,982
2.52
23,349
1:1
46,698

184,518
1
0.02
184,518
1.26
23,352
1:1
23,352

196,479
1
0.02
196,479
1.34
24,844
1:1
24,844

276,750
1
0.02
276,750
1.89
34,859
1:1
34,859

461,160
3
0.07
1,383,480
9.43
57,666
1:1
173,598

553,500
1
0.02
553,500
3.77
69,387
1:1
69,387

Total
4365
100.00
14,664,213
100.00

3,273,663

*1 additional Equity Share has been allotted to Category 1,863 in the
ratio of 19:73

D.
Allotment to Eligible
Employee (after technical rejections)

The Basis of Allotment to the
Employee Investors who have bid at the Offer Price of Rs. 542 per Equity Share or above (a
discount of Rs. 20 per Equity Share was offered to Eligible Employees bidding under
Employee Reservation Portion), was finalized in consultation with NSE. This category has
been subscribed to the extent of 0.14706 times. The total number of Equity Shares allotted
in this category is 44,118 Equity Shares to 189 successful applicants. The category-wise
details of the Basis of Allotment ate as under.

Category
No.
of Applications Received
%of
Total
Total
No. of Equity Shares applied
%
to Total
No.
of Equity Shares allotted per applicant
Ratio
Total
No. of Equity Shares Allotted

27
39
20.63
1,053
2.39
27
1:1
1,053

54
32
16.93
1,728
3.92
54
1:1
1,728

81
18
9.52
1,458
3.30
81
1:1
1,458

108
10
5.29
1,080
2.45
108
1:1
1,080

135
5
2
65
675
1.53
135
1:1
675

162
5
2.65
810
1.84
162
1:1
810

189
7
3.70
1,323
3.00
189
1:1
1,323

216
5
2.65
1,080
2.45
216
1:1
1,080

243
1
0.53
243
0.55
243
1:1
243

270
5
2.65
1,350
3.06
270
1:1
1,350

297
4
2.12
1,188
2.69
297
1:1
1,188

324
2
1.06
648
1.47
324
1:1
648

351
10
5.29
3,510
7.96
351
1:1
3,510

378
8
4.23
3,024
6.85
378
1:1
3,024

405
4
2.12
1,620
3.67
405
1:1
1,620

486
3
1.59
1,458
3.30
486
1:1
1,458

540
6
3.17
3,240
7.34
540
1:1
3,240

567
9
4.76
5,103
11.57
567
1:1
5,103

675
1
0.53
675
1.53
675
1:1
675

702
1
0.53
702
1.59
702
1:1
702

729
1
0.53
729
1.65
729
1:1
729

756
1
0.53
756
1.71
756
1:1
756

783
1
0.53
783
1.77
783
1:1
783

810
3
1.59
2,430
5.51
810
1:1
2,430

918
4
2.12
3,672
8,32
918
1:1
3,672

945
4
2.12
3,780
8.57
945
1:1
3,780

TOTAL
189
100.00
44,118
100.00

44,118

Unsubscribed portion of 246,440 Equity Shares spited over to QIBs NIB
and Retail Categories in the ratio of 50:15:35.

E.
Allotment to QIBs
(excluding Anchor Investors) (after technical rejections)

Allotment to QIBs, who have
Bid at the Offer Price of Rs. 542 per Equity Share or above, has been done on a
proportionate basis in consultation with NSE. This category has been subscribed to the
extent of 29.06617 times (including spillover from Employee and Retail Individuals
categories). As per the SEBI Regulations Mutual Funds were Allotted 5% of the Equity
Shares of QIB Portion available i.e., 385,246 Equity Shares (including spillover of 96,465
Equity Shares from Employee and Retail categories) and other QIBs and unsatisfied demand
of Mutual Funds were Allotted the remaining available Equity Shares i.e., 7,319,657 Equity
Shares (including spillover of 1,929,298 Equity Shares from Employee and Retail
categories) on a proportionate basis. The total number of Equity Shares Allotted in the
QIB Portion is 7,704,903 Equity Shares, which were allotted to 71 successful QIB Bidders.
The category-wise details of the Basis of Allotment are as under:

Category
FIs/Banks
FIls/FPIs
IC
MFs
OTHs
Total

QIB
1,730,953
3,759,816
394,638
740,570
1,078,926
7,704,903

F.
Allotment to Anchor
Investors

The Company, Dr Ramesh
Kancharia (acting on behalf of the other Promoter Selling Shareholders and the Other
Selling Shareholder) and the Investor Selling Shareholders, in consultation with the
BRLMs, have allocated 8,663,404 Equity Shares to 23 Anchor Investors (through 36
Applications) at the Anchor Investor Offer Price of Rs. 542 per Equity Share in accordance
with the SEBI Regulations. This represents 60% of the QlB Portion.

Category
MFs
ICs
AIFs
FPI/Flls
Total

Anchor
3,897,396
738,072
369,036
3,658,900
8,663,404

The IPO Committee o(our Company on May 5, 2022, has taken on record the
Basis of Allotment of Equity Shares approved by the Designated Stock Exchange, being NSE
and has allotted the Equity Shares to various successful Bidders. The Allotment
Advice-cum-Unblocking Intimations and/ or notices has been emailed or dispatched to the
address of the investors as registered with the depositories. Further, the instructions to
the Self Certified Syndicate Banks for unblocking of funds, transfer to Pubic Offer
Account has been issued on May 5, 2022, and payment to non-Syndicate brokers have been
issued on May 6, 2022. In case the same is not received within ten days, investors may
contact the Registrar to the Offer at the address given below. The Equity Shares Allotted
to the successful Allottees have been uploaded on May 6, 2022 for credit into the
respective beneficiary accounts subject to validation of the account details with the
depositories concerned. The Company has filed the Listing application with NSE and BSE on
May 6, 2022. The Company has received listing and trading approval from NSE and BSE and
the trading will commence on May 10, 2022.

Note All capitalized terms used and not specifically defined herein
shall hare the same meaning as ascribed to them in the Prospectus.

INVESTORS, PLEASE NOTE

The details of the allotment made will be hosted on the website of the
Registrar to the Offer, KFin Technologies Limited at: www.kfintech.com

All future correspondence in this regard may kindly be addressed to the
Registrar to the Offer quoting full name of the First/ sole Bidder, Bid cum Application
Form number, Bidder DP ID, Client ID, PAN, date of submission of Bid cum Application Form,
address of the Bidder, number of Equity Shares applied for the name and address of the
Designated Intermediary where the Bid cum Application Form was submitted by the Bidder and
a copy of the Acknowledgment Slip received from the Designated Intermediary at the address
given below:

KFin Technologies Limited
(formerly known as KFin Technologies Private Limited)

Selenium, Tower-B, Plot 31
and 32, Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareddi - 500
032,

Telangana, India. Telephone:
+914067162222

E-mail: rcml.ipo@kfintech.com

Website: www.kfintech.com

Investor Grievance ID: emward.ris@kfintech.com

Contact Person: M Murali
Krishna

SEBI Registration Number:
INR000000221

For RAINBOW CHILDREN'S
MEDICARE LIMITED

On behalf of the Board of
Directors

Sd/-

Place: Hyderabad, Telangana
Ashish Kapil

Date:
May 9, 2022
Company Secretary and Compliance Officer

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF
EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF
RAINBOW CHILDREN'S MEDICARE LIMITED.

RAINBOW CHILDREN'S MEDICARE LIMITED has filed the Prospectus dated
May 2, 2022 with RoC and thereafter with SEBI and Stock Exchanges. The Prospectus is
available on the website of SEBI at www.sebi.gov.in
websites of BSE Limited and National Stock Exchange of India Limited at www.bseindia.com and www.nseindia.com,
respectively and is available on the websites of the BRLMs. i.e. Kotak Mahindra Capital
Company Limited, J.P. Morgan India Private Limited and IIFL Securities Limited at https://investmentbank.kotak.com, www.jpmipt.com and www.iiftcap.com,
respectively. Investors should note that investment in equity shares invokes a high degree
of risk and for details relating to such risk, refer to the Prospectus, including the
section titled 'Risk Factors' of the Prospectus. Specific attention of the investors is
invited to 'Risk Factors' beginning on page 47 of the Prospectus.

The Equity Shares offered in the Offer have not been and will not be
registered under the U.S. Securities Act or any other applicable law of the United States
and. unless so registered, may not be offered or sold within the United States, except
pursuant to an exemption from, or in a transaction not subject to, the registration
requirements of the U.S. Securities Act and applicable state securities laws. Accordingly,
the Equity Shares are being offered and sold (i) within the United States only to persons
reasonably believed to be "qualified institutional buyers" (as defined m Rule
144A under the U.S. Securities Act and referred to in this Prospectus as "U.S.
QIBs" for the avoidance of doubt, the term U.S. QIBs does not refer to a category of
institutional investor defined under applicable Indian regulations and referred to in this
Prospectus as 'OIBs') pursuant to Section 4(a) of the U.S. Securities Act, and (ii)
outside the United States in offshore transactions in compliance with Regulation S under
the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and
sales occur.}

Rainbow Children Medicare IPO Basis of Allotment FAQs

The IPO allocation is based on the subscription level and the investor category.

Refer to IPO allotment rules and methods for more details.

See the basis of allotment document above to know how the shares are allocated in Rainbow Children Medicare IPO .

The Rainbow Children Medicare IPO basis of allotment (published above) tells you how shares are allocated to you in Rainbow Children Medicare IPO and category wise demand of IPO share.

Visit the Rainbow Children Medicare IPO allotment status page to check the number of shares allocated to your application.

In Rainbow Children Medicare IPO allotment process, the registrar separates valid and invalid applications. The invalid applications with technical errors are rejected and only valid applications at or above the cut-off price are considered for allotment.

For more information, please refer to IPO Allotment Process and Basis of Allotment.

Check the Rainbow Children Medicare IPO basis of allotment document to know how the shares are allocated in Rainbow Children Medicare IPO.

Rainbow Children Medicare IPO Basis of Allotment

Rainbow Children Medicare IPO Basis of Allotment FAQs

How shares are allotted in Rainbow Children Medicare IPO?

What is Rainbow Children Medicare IPO basis of allotment status?

What is Rainbow Children Medicare IPO allotment process?

Read more about Rainbow Children Medicare IPO